JOURNAL CONTENT
CONTACT

Submission of the manuscript is online via e-mail
ecgarticle@gmail.com or
cholerez@mail.ru

Tel: +7 903 250 5288

Editorial Correspondence e-mail
gastrossr@gmail.com


Publishing, Subscriptions, Sales and Advertising, Correspondence e-mail
journal@cniig.ru

Tel: +7 917 561 9505

THE RULES OF SUBMITTING AN ARTICLE

READ

Scimago Journal & Country Rank

SCImago Journal & Country Rank

LECTION

    1. Saint-Petersburg state pediatric medical University (St. Petersburg, Russian Federation)

    Keywords:Nonceliac sensitivity to gluten,allergies to wheat,celiac disease

    Abstract:Nonceliac sensitivity to gluten (NCSG) is a new syndrome manifested by a gluten intolerance is not allergic and non-autoimmune condition in which eating gluten can cause symptoms similar to the manifestations of celiac disease. NCSG the diagnosis requires the exclusion of coeliac disease and allergies to wheat. NCSG occurs mainly by intestinal symptoms that appear soon after eating gluten-containing foods and are rapidly after discontinuation of gluten. NCSG is not accompanied by retardation in physical and sexual development, weight loss and autoimmune or allergic comorbidity. The basis for the development of this syndrome probably is the effect of microbiota and metabolites of gluten on the neuroreceptors, as well as a mild inflammation of the intestinal mucosa without atrophy. NCSG more characteristic of adults than children and often manifests at a young age. The article presents the differential diagnostic signs of NCSG, celiac disease and allergies to wheat.

      1. Shewry P. R. Wheat - J. Exp.Botanics -2009, v.60, p.1537-1553
      2. Rubio-Tapia A., Ludvigsson J. F., Brantner T. L., et al. The prevalence of celiac disease in the United States - Am. J. Gastroenterol., 2012, v.107, p.1538-1544.
      3. Czaja-Bulsa G. Non coeliac gluten sensitivity - a new disease with gluten intolerance - Clinical Nutr., 2014, http://dx.doi.org/10.1016/j.clnu.2014.08.012
      4. Catassi c., Bai J. C., Bonaz B., et al. Non-celiac gluten sensitivity^ the new frontier of gluten related disorders. - Nutrients, 2013; v.5, p.3839-3853.
      5. Sapone A., Bai J. C., Ciacci C., Dolincek J., et al. Spectrum of gluten-related disorders consensus on new nomenclature and classification - BMC Med., 2012, v.10, p.13.
      6. Ludvigsson J. F., Leffler D. A., Bai J. C., et al. The Oslo definitions for coeliac disease and related terms - Gut, 2013, v.62, p.43-52.
      7. Wahnschaffe U., Ulrich R., Riecken E. O., Schulzke J. D. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome - Gastroenterology, 2001, v.121, p.1329-1338.
      8. Inomata N. Wheat allergy - Curr.Opin.Allergy Clin Immunol., 2009, v.9, p.238-243.
      9. Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications - Clin. Gastroenterol.Hepatol, 2012, v.10, p.1096-1100.
      10. Mazzarella G., Stefanile R., Camarca A., et al. Gliadin activates HLA class 1-restricted CD 8+ T-cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis - Gastroenterology, 2008, v.134, p.1017-1027.
      11. Tursi A. Gastrointestinal motility disturbances in celiac disease - J. Clin.Gastroenterol, 2004, v.38, p.642-645.
      12. Barrett J. S., Gibson P. R. Fermentable oligosaccharides, disaccharides, monosaccharides and poliols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals& - Therap.Adv.Gastroenterol., 2012, v.5, p.261-268.
      13. Leon F., Sanches L., Camarero C., Roy G. Cytocine production by intestinal intraepithelial lymphocyte subsets in celiac disease - Dig.Dis.Sci, 2005, v.50, p.593-600.
      14. Monteleone I., Serra M., Del Vecchio Blanco G., et al. Characterization of IL-17A-proucing cells in celiac disease mucosa - J. Immunol, 2010, v.184, p.2211-2218.
      15. Mansueto P., Seidita A, D’Alcamo A., et al. Non-celiac gluten sensitivity: literature review - J. Amer. College Nutr., 2014, http://www.tandfonline.com/loi/uacn20
      16. Hmida N. B., Ben Ahmed M., Moussa A., et al. Impaired control of effector T cells by regulatory T-cells: a clue to loss of oral tolerance and autoimmunity in celiac disease? - Am. J. Gastroenterol., 2012, v.107, p.604-611.
      17. Josefowicz S. Z., Lu L. F., Rudensky A. Y. Regulatory T cells mechanisms of differentiation and function - Ann.Rev.Immunol., 2012, v.30, p.531-564.
      18. Kalliomaki M., Satokari R., Lahteenoja H., et al. Expression of microbiota, toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. - J. Pediatric Gastroenterol., 2012, v.54, p.727-732.
      19. Sapone A., Lammers K. M., Casolaro V., et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity - BMC Med., 2-11, v.9, p.23.
      20. Oboki K., Ohno T., Salto H., Nakae S. Th17 and allergy - Allergol.Int., 2008, v.57, p.121-134.
      21. Volta U., Tovoli F., Cicola R., ett al. Serological tests in gluten sensitivity (nonceliac gluten intolerance) - J. Clin.Gastroenterol., 2012, v.46, p.680-685.
      22. Jackson J. R., Eaton W. W., Cascella N. G., et al. Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity - Psychiatr Q, v.83, p.91-102.
      23. Camilleri M., Madsen K., Spiller R., et al. Intestinal barrier function in health and gastrointestinal disease. - Neurogastroenterol. Motil., 2012, v.24, 503-512.
      24. Makela M. J., Eriksson C., Kotaniemi-Syrjanen A., et al. Wheat allergy in children - new tools for diagnostics - Clin.Experim.Allergy, 2014, v.44, p.1420-1430.
      25. Marcason W. What is the current status of research concerning use of a gluten-free, casein-free diet for children diagnosed with autism? - J. Am. Diet.Assoc., 2009, v.109(3), p.572.
      26. Lachance L. R., McKenzie K. Biomarkers of gluten sensitivity in patients with non-affective psychosis: a meta-analysis - Schisophr.Res., 2013, http:/dx.doi.org/10.1016/j.schres.2013.12.001
      27. Cascella N. G., Santora D., Gregory P., et al. Increased prevalence of transglutaminase 6 antibodies in sera from schizophrenia patients - Schizophr.Bull., 2013, v.39, p.867-871.
     


    Full text is published :
    Kornienko E.A. NONCELIAC SENSITIVITY TO GLUTEN. Experimental and Clinical Gastroenterology Journal. 2017;139(03):89-98
    Read & Download full text

    1. A. N. Ryzhikh State scientific center of coloproctology (Moscow, Russian Federation)

    Keywords:Biofeedback therapy (BFB-therapy),constipation

    Abstract:Biofeedback therapy (BFB-therapy) is one of the main treatment modalities for constipation caused by functional defecation disorder. This review contains and update on effectiveness and methods of BFB-therapy. Described are inclusion criteria for BFB-therapy based on Rome IV consensus as well as standard treatment protocol developed by US and European Societies of neurogastroenterology and motility. Perspectives for future research in BFB-therapy for chronic constipation are proposed

      1. Sanchez MIP, Bercik P. Epidemiology and burden of chronic constipation. Can J Gastroenterol. 2011;25 Suppl B(Suppl B):11B-15B.
      2. Rao SSC, Seaton K, Miller MJ, et al. Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation. J Psychosom Res. 2007;63(4):441-449.
      3. Hamid SS, Malfertheiner P, et al. World Gastroenterology Organisation Global Guideline: Constipation. J Clin Gastroenterol. 2011;45(6):483-487.
      4. Rao SSC, Bharucha AE, Chiarioni G, et al. Anorectal Disorders. Gastroenterology. 2016;150(6):1430-1442.e4.
      5. Nullens S, Nelsen T, Camilleri M, et al. Regional colon transit in patients with dyssynergic defaecation or slow transit in patients with constipation. Gut. 2012;61(8):1132-1139.
      6. Rao SS, Patel RS. How useful are manometric tests of anorectal function in the management of defecation disorders? Am J Gastroenterol. 1997;92(3):469-475.
      7. Rao SSC, Mudipalli RS, Stessman M, Zimmerman B. Investigation of the utility of colorectal function tests and Rome II criteria in dyssynergic defecation (Anismus). Neurogastroenterol Motil. 2004;16(5):589-596.
      8. Lee HJ, Jung KW, Myung S-J. Technique of functional and motility test: how to perform biofeedback for constipation and fecal incontinence. 2013;19(4).
      9. Фоменко ОЮ, Титов АЮ, Бирюков ОМ, Мудров АА, Белоусова СВ. Характер функциональных нарушений мышц тазового дна у пациентов с обструктивной дефекацией. Колопроктология. 2016;(S 1):46-47.
      10. Титов АЮ, Бирюков ОМ, Фоменко ОЮ, Войнов МА. Метод биологической обратной связи в лечении проктогенных запоров у взрослых пациентов. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014;24(5):78-81.
      11. Фоменко ОЮ, Титов АЮ, Бирюков ОМ, Мудров АА, Белоусова СВ, Егорова ДВ. Диагностика и консервативное лечение функциональных расстройств дефекации. Колопроктология. 2016;(3 (57)):47-53.
      12. Rao SSC. Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am. 2008;37(3):569-86.
      13. Rao SSC, Welcher KD, Pelsang RE. Effects of biofeedback therapy on anorectal function in obstructive defecation. 1997;42(11).
      14. Lacy BE, Mearin F, Chang L, et al. Bowel Disorders. Gastroenterology. 2016;150(6):1393-1407.e5.
      15. Rao SSC, Benninga MA, Bharucha AE, Chiarioni G, Di Lorenzo C, Whitehead WE. ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil. 2015;27(5):594-609.
      16. Tantiphlachiva K, Rao P, Attaluri A, Rao SSC. Digital Rectal Examination Is a Useful Tool for Identifying Patients With Dyssynergia. Clin Gastroenterol Hepatol. 2010;8(11):955-960.
      17. Minguez M, Herreros B, Sanchiz V, et al. Predictive value of the balloon expulsion test for excluding the diagnosis of pelvic floor dyssynergia in constipation. Gastroenterology. 2004;126(1):57-62.
      18. Ratuapli S, Bharucha AE, Harvey D, Zinsmeister AR. Comparison of rectal balloon expulsion test in seated and left lateral positions. Neurogastroenterol Motil. 2013;25(12): e813-20.
      19. Rao SS. Dyssynergic defecation. Gastroenterol Clin North Am. 2001;30(1):97-114.
      20. Rao SSC, Kavlock R, Rao S. Influence of Body Position and Stool Characteristics on Defecation in Humans. Am J Gastroenterol. 2006;101(12):2790-2796.
      21. Chiarioni G, Kim SM, Vantini I, Whitehead WE. Validation of the Balloon Evacuation Test: Reproducibility and Agreement With Findings From Anorectal Manometry and Electromyography. Clin Gastroenterol Hepatol. 2014;12(12):2049-2054.
      22. Ratuapli SK, Bharucha AE, Noelting J, et al. Phenotypic Identification and Classification of Functional Defecatory Disorders Using High-Resolution Anorectal Manometry. Gastroenterology. 2013;144(2):314-322.e2.
      23. Grossi U, Carrington E V, Bharucha AE, Horrocks EJ, Scott SM, Knowles CH. Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation. Gut. 2016;65(3):447-455.
      24. Diamant NE, Kamm MA, Wald A, et al. AGA technical review on anorectal testing techniques. Gastroenterology. 1999;116(3):735-760.
      25. Penninckx F, Debruyne C, Lestar B, Kerremans R. Observer variation in the radiological measurement of the anorectal angle. Int J Colorectal Dis. 1990;5(2):94-97.
      26. Ferrante SL, Perry RE, Schreiman JS, Cheng SC, Frick MP. The reproducibility of measuring the anorectal angle in defecography. Dis Colon Rectum. 1991;34(1):51-55.
      27. Shorvon PJ, McHugh S, Diamant NE, Somers S, Stevenson GW. Defecography in normal volunteers: results and implications. Gut. 1989;30(12):1737-1749.
      28. Rao SSC. Biofeedback therapy for constipation in adults. Best Pract Res Clin Gastroenterol. 2011;25(1):159-166.
      29. Pelsang RE, Rao SSC, Welcher K. FECOM: a new artificial stool for evaluating defecation. Am J Gastroenterol. 1999;94(1):183-186.
      30. Rao SSC, Valestin J, Brown CK, Zimmerman B, Schulze K. Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial. Am J Gastroenterol. 2010;105(4):890-896.
      31. Rao SSC, Seaton K, Miller M, et al. Randomized Controlled Trial of Biofeedback, Sham Feedback, and Standard Therapy for Dyssynergic Defecation. Clin Gastroenterol Hepatol. 2007;5(3):331-338.
      32. Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129(1):86-97.
      33. Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized, Controlled Trial Shows Biofeedback to be Superior to Alternative Treatments for Patients with Pelvic Floor Dyssynergia-Type Constipation. Dis Colon Rectum. 2007;50(4):428-441.
      34. Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G. Biofeedback Is Superior to Laxatives for Normal Transit Constipation Due to Pelvic Floor Dyssynergia. Gastroenterology. 2006;130(3):657-664.
      35. Koh CE, Young CJ, Young JM, Solomon MJ. Systematic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction. Br J Surg. 2008;95(9):1079-1087.
      36. Shim LSE, Jones M, Prott GM, Morris LI, Kellow JE, Malcolm A. Predictors of outcome of anorectal biofeedback therapy in patients with constipation. Aliment Pharmacol Ther. 2011;33(11):1245-1251.
      37. Go J, Valestin J, Brown CK, et al. Is Biofeedback Therapy Effective in Improving Quality of Life in Dyssynergic Defecation? A Randomized Clinical Trial. Gastroenterology. 2011;140(5): S-52.
      38. Bharucha AE, Dorn SD, Lembo A, Pressman A, Pressman A. American Gastroenterological Association Medical Position Statement on Constipation. Gastroenterology. 2013;144(1):211-217.
      39. Ивашкин ВТ, Абдулхаков СР, Баранская ЕК, с соавт. Клинические рекомендации российской гастроэнтерологической ассоциации по диагностике и лечению взрослых пациентов с хроническим запором. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2014;24(6):69-76.
      40. Kawimbe BM, Papachrysostomou M, Binnie NR, Clare N, Smith AN. Outlet obstruction constipation (anismus) managed by biofeedback. Gut. 1991;32(10):1175-1179.
      41. Patankar SK, Ferrara A, Levy JR, Larach SW, Williamson PR, Perozo SE. Biofeedback in colorectal practice: a multicenter, statewide, three-year experience. Dis Colon Rectum. 1997;40(7):827-831.
      42. Rao SS, Valestin J, Brown CK, et al. Home or Office Biofeedback Therapy for Dyssynergic Defecation - Randomized Controlled Trial. Gastroenterology. 2011;140(5): S-160.
     


    Full text is published :
    Golovenko A.O., Fomenko O.Yu., Egorova D.V., Belous S.S. BIOFEEDBACK THERAPY FOR TREATMENT OF CHRONIC CONSTIPATION. Experimental and Clinical Gastroenterology Journal. 2017;139(03):99-105
    Read & Download full text